Summit Therapeutics Inc. (SMMT)
USD 16.98
(-8.56%)
USD 16.98
(-8.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 704.29 Thousand | 1.8 Million | 860 Thousand | 811.37 Thousand | 56.41 Million |
| Cost of Revenue | 2.05 Million | 2.51 Million | - | - | 199.49 Thousand | 24.91 Thousand |
| Gross Profit | -2.05 Million | -1.8 Million | 1.8 Million | 860 Thousand | 611.87 Thousand | 56.38 Million |
| Operating Expenses | 87.68 Million | 64.28 Million | 87.99 Million | 53.19 Million | 53.92 Million | 47.68 Million |
| Selling, General and Administrative Expenses | 28.21 Million | 26.7 Million | 23.61 Million | 19.23 Million | 11.93 Million | 16.18 Million |
| Research and Development Expenses | 59.47 Million | 51.99 Million | 85.35 Million | 53.27 Million | 41.98 Million | 51.37 Million |
| Other Expenses | - | -14.41 Million | -20.96 Million | -19.31 Million | - | -19.87 Million |
| Cost and Expenses | 89.73 Million | 64.28 Million | 87.99 Million | 53.19 Million | 55.71 Million | 47.68 Million |
| Operating Income | -89.73 Million | -72.08 Million | -86.18 Million | -53.19 Million | -54.9 Million | 12.38 Million |
| Interest Expense | 16.46 Million | 4.4 Million | 281 Thousand | 255 Thousand | 41.75 Thousand | 556.1 Thousand |
| Income Tax Expense | -946 Thousand | -4.4 Million | -2.45 Million | -213 Thousand | -5.8 Million | -3.27 Million |
| Earnings before Tax | -615.87 Million | -78.78 Million | -88.6 Million | -52.91 Million | -36.46 Million | 6.59 Million |
| Net Income | -614.92 Million | -74.38 Million | -86.14 Million | -52.69 Million | -30.66 Million | 9.87 Million |
| Earnings Per Share Basic | -0.99 | -0.38 | -0.93 | -0.76 | -0.19 | 0.11 |
| Earnings Per Share Diluted | -0.99 | -0.38 | -0.93 | -0.76 | -0.19 | 0.11 |
| Weighted Average Shares Outstanding | 619.64 Million | 193.33 Million | 92.23 Million | 69.52 Million | 164.14 Million | 86.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 619.64 Million | 193.33 Million | 92.23 Million | 69.52 Million | 164.14 Million | 86.14 Million |
| Gross Margin | - | -2.57 | 1.00 | 1.00 | 0.75 | 1.00 |
| EBIT Margin | - | -86.33 | -47.64 | -59.85 | -65.46 | 0.25 |
| Profit Margin | - | -105.61 | -47.62 | -61.28 | -37.79 | 0.17 |
| EBITDA | 1 Million | -52.63 Million | -62.73 Million | -37.13 Million | -21.56 Million | 11.65 Million |
| Earnings Before Tax Margin | - | -102.36 | -47.64 | -61.85 | -67.66 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | -235 Thousand | - | - |
| Cost of Revenue | 19.99 Thousand | 20 Thousand | 27 Thousand | 605 Thousand | 2.05 Million | 599 Thousand |
| Gross Profit | -19.99 Thousand | -20 Thousand | -27 Thousand | -840 Thousand | -2.05 Million | -599 Thousand |
| Operating Expenses | 58.37 Million | 44.74 Million | 42.38 Million | 36.24 Million | 87.68 Million | 20.75 Million |
| Selling, General and Administrative Expenses | 20.39 Million | 13.95 Million | 11.72 Million | 11.61 Million | - | 5.43 Million |
| Research and Development Expenses | 37.72 Million | 30.79 Million | 30.87 Million | 24.81 Million | - | 15.32 Million |
| Other Expenses | 264 Thousand | 15 Million | - | -104 Thousand | 520.91 Million | -64 Thousand |
| Cost and Expenses | 58.37 Million | 44.76 Million | 42.38 Million | 36.24 Million | 89.73 Million | 20.75 Million |
| Operating Income | -58.37 Million | -44.76 Million | -42.38 Million | -36.21 Million | -89.73 Million | 265 Thousand |
| Interest Expense | 2.45 Million | 3.1 Million | 3.12 Million | 2.89 Million | 16.46 Million | 2.72 Million |
| Income Tax Expense | -56.25 Million | -159 Thousand | 3.12 Million | 2.79 Million | -946 Thousand | -599 Thousand |
| Earnings before Tax | -56.25 Million | -60.54 Million | -43.47 Million | -36.56 Million | -615.87 Million | -21.26 Million |
| Net Income | -56.25 Million | -60.38 Million | -43.47 Million | -36.56 Million | -614.92 Million | -21.26 Million |
| Earnings Per Share Basic | -0.08 | -0.09 | -0.06 | -0.05 | - | -0.03 |
| Earnings Per Share Diluted | -0.08 | -0.09 | -0.06 | -0.05 | - | -0.03 |
| Weighted Average Shares Outstanding | 726.65 Million | 707.9 Million | 701.78 Million | 701.66 Million | 619.64 Million | 697.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 726.65 Million | 707.9 Million | 701.78 Million | 701.66 Million | 619.64 Million | 697.73 Million |
| Gross Margin | - | - | - | 3.57 | - | - |
| EBIT Margin | - | - | - | 141.85 | - | - |
| Profit Margin | - | - | - | 155.60 | - | - |
| EBITDA | -53.77 Million | -44.74 Million | -42.36 Million | -33.33 Million | - | 265 Thousand |
| Earnings Before Tax Margin | - | - | - | 154.09 | - | - |
MAAFF
0071
0207
AIRYY
5255
JBL